Starflo glaucoma implant: early experience in Hungary
- PMID: 27220226
- PMCID: PMC5712912
Starflo glaucoma implant: early experience in Hungary
Abstract
Aim: To present the early experience with the implantation technique, safety and efficiency of STARflo device for open angle glaucoma (OAG).
Methods: referring intra- and postoperative clinical experience with a series of seven cases in three glaucoma centers in Hungary.
Results: No intraoperative complications were observed. Postoperative inflammatory signs disappeared rapidly. The mean IOP reduction was from 27.6 ± 5.0 mmHg to 18.9 ± 3.4 mmHg (32% reduction/ patient) at six months postoperatively.
Conclusion: STARflo implant was safe and (except for one case with neovascular glaucoma) effective in our cases. The learning curve for experienced anterior segment surgeons was short.
Figures







References
-
- Samples , et al. Surgical Innovations in Glaucoma. 38
-
- Böke H. History of cyclodialysis. In memory of Leopold Heine 1870-1940. Klin Monbl Augenheilkd. 1990 Oct;197(4):340–348. - PubMed
-
- Pourjavan S, et al. STARflo glaucoma implant: 12 month clinical results. Acta Ophthalmol. 2013;91:252–250.
-
- Collignon N, et al. STARflo: A suprachoroidal drainage implant made from STAR biomaterial. Surgical Innova- tions in Glaucoma. 2014;0:235–251.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources